Nuvectra Corporation (NVTR) Tops Q2 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Nuvectra™ Reports Second Quarter 2017 Financial Results
August 8, 2017 4:01 PM EDTPLANO, Texas, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced financial results for the second quarter ended June 30, 2017.
Highlights
Record consolidated revenues of $7.2 million, including total Algovita® sales of $5.5 millionCompleted FDA regulatory submission for full-body MRI-conditional approval for the Algovita SCS systemOn track with the Virtis U.S. and European regulatory approval timelinesScott Drees, CEO, said, During the second quarter our U.S. commercial organization, which includes approximately 50 active... More
